全身麻醉剖宫产瑞芬太尼对产妇及新生儿安全性的影响分析

The Effect of Remifentanil on Cesarean Section With General Anesthesia on the Safety of Pregnant Women and Newborns

目的分析全身麻醉剖宫产瑞芬太尼对产妇及新生儿安全性的影响。方法选择2016年3月—2017年12月足月妊娠剖宫产产妇,共计76例,随机分为研究组(38例)、对照组(38例),分别予以瑞芬太尼全麻、普通全麻。分析组间新生儿Apgar评分及脐带血气分析情况。结果研究组与对照组之间的新生儿Apgar评分及脐带血气分析指标差异不存在统计学意义,P>0.05。结论对足月妊娠剖宫产产妇予以瑞芬太尼全麻,能够保证产妇及新生儿安全。

Objective To analyze the effect of remifentanil on cesarean section with general anesthesia on the safety of pregnant women and newborns. Methods A total of 76 cases of cesarean section of term pregnancy were selected from March 2016 to December 2017 and randomly divided into study group （38 cases） and control group （38 cases）. Remifentanil general anesthesia and general anesthesia were given respectively. The Apgar score of newborn and the analysis of umbilical cord blood gas analysis were analyzed. Results There was no statistical significance between the Apgar score and the umbilical cord blood gas analysis between the study group and the control group, P 〉 0.05. Conclusion The general anesthesia of remifentanil for cesarean section of full term pregnancy can guarantee the safety of the pregnant women and thenewborn.